JPWO2021067335A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021067335A5
JPWO2021067335A5 JP2022520290A JP2022520290A JPWO2021067335A5 JP WO2021067335 A5 JPWO2021067335 A5 JP WO2021067335A5 JP 2022520290 A JP2022520290 A JP 2022520290A JP 2022520290 A JP2022520290 A JP 2022520290A JP WO2021067335 A5 JPWO2021067335 A5 JP WO2021067335A5
Authority
JP
Japan
Prior art keywords
chemical formula
pharmaceutically acceptable
following chemical
compound
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022520290A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022551583A (ja
JP2022551583A5 (https=
JP7854389B2 (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/053369 external-priority patent/WO2021067335A1/en
Publication of JP2022551583A publication Critical patent/JP2022551583A/ja
Publication of JP2022551583A5 publication Critical patent/JP2022551583A5/ja
Publication of JPWO2021067335A5 publication Critical patent/JPWO2021067335A5/ja
Application granted granted Critical
Publication of JP7854389B2 publication Critical patent/JP7854389B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022520290A 2019-10-01 2020-09-30 Ｋｌｋ５／７デュアル阻害剤としてのベンゾキサジノン化合物 Active JP7854389B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962909006P 2019-10-01 2019-10-01
US62/909,006 2019-10-01
PCT/US2020/053369 WO2021067335A1 (en) 2019-10-01 2020-09-30 Benzoxazinone compounds as klk5/7 dual inhibitors

Publications (4)

Publication Number Publication Date
JP2022551583A JP2022551583A (ja) 2022-12-12
JP2022551583A5 JP2022551583A5 (https=) 2023-09-29
JPWO2021067335A5 true JPWO2021067335A5 (https=) 2023-09-29
JP7854389B2 JP7854389B2 (ja) 2026-05-01

Family

ID=

Similar Documents

Publication Publication Date Title
RU2606947C2 (ru) Борсодержащие малые молекулы
JP5389668B2 (ja) 皮膚浸透率の非常に高い１Ｈ−イミダゾ［４，５−ｃ］キノリン−４−アミン及び関連化合物の正に荷電した水溶性プロドラッグ
TWI689490B (zh) 用於治療纖維化之經取代之芳族化合物及相關方法
JP2001506267A (ja) アミノステロールエステル化合物
JP2002539243A (ja) 受精能を向上させるための組成物
JP2003515580A (ja) （ｓ）−２−エトキシ−３−〔４−（２−［４−メタンスルホニルオキシフェニル］エトキシ）フェニル〕プロパン酸の微粉砕形
JP2562475B2 (ja) 新規化合物、医療組成物、及び炎症及び痛みの治療方法
JP2003516327A (ja) アテローム性動脈硬化の予防および／または治療方法
CN110613726B (zh) 核苷化合物的应用
JPH08109131A (ja) Ｈｉｖプロテアーゼ抑制因子組成物
CN113101289A (zh) 烟酰胺在制备治疗手足皮肤反应制剂中的应用
JP7839265B2 (ja) Ｃｌｙシリーズ化合物及びその調製方法並びにその調製薬物の用途
US20180085345A1 (en) Methods of tracking skin conditions using cyclolignan compounds
RU2004102398A (ru) Производные бензо[g]хинолина для лечения глаукомы и близорукости
JPH10513186A (ja) Ｈｉｖプロテアーゼ阻害剤インジナビル及び逆転写酵素阻害剤３ｔｃを必要に応じてａｚｔ、ｄｄｉ、又はｄｄｃと共に用いるｈｉｖ感染の組合せ治療
JPWO2021067335A5 (https=)
US20220105082A1 (en) New formulations containing leukotriene receptor antagonists
EP3435990B1 (en) Stable pharmaceutical compositions for topical administration and uses thereof
JP2003512425A (ja) ６−メトキシ−２−ナフチル酢酸プロドラッグ
TW201811307A (zh) 2-(2-乙氧基-2-氧代乙基)(甲基)胺基-2-氧代乙基5-(十四烷氧基)呋喃-2-羧酸酯之皮膚調配物
FR2470110A1 (fr) Derives de la decrapenylamine, leurs sels acides d'addition et composition pharmaceutique renfermant ces produits
JP2659428B2 (ja) テルルおよびセレン誘導体の複合体
CN111320662A (zh) 一类n-苄基取代的二脒那秦衍生物及其药物用途
CN117088862B (zh) 一种硫代色元酮衍生物和应用
CN112022869A (zh) 野黄芩苷的医药用途